WallStreetZenWallStreetZen

NYSE: TEVA
Teva Pharmaceutical Industries Ltd Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for TEVA

Based on 2 analysts offering 12 month price targets for Teva Pharmaceutical Industries Ltd.
Min Forecast
$13.00+33.88%
Avg Forecast
$13.00+33.88%
Max Forecast
$13.00+33.88%

Should I buy or sell TEVA stock?

Based on 2 analysts offering ratings for Teva Pharmaceutical Industries Ltd.
Strong Buy
Strong Buy
2 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their TEVA stock forecasts and price targets.

TEVA stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2023-11-27
lockedlocked$00.00+00.00%2023-09-08Find Out Why

1 of 1

Forecast return on equity

Is TEVA forecast to generate an efficient return?
Company
N/A
Industry
0.05%
Market
30.07%

Forecast return on assets

Is TEVA forecast to generate an efficient return on assets?
Company
N/A
Industry
0.03%

TEVA revenue forecast

What is TEVA's revenue in the next 3 years based on estimates from 6 analysts?
Avg 1 year Forecast
$15.4B+0.51%
Avg 2 year Forecast
$15.3B+0.46%
Avg 3 year Forecast
$15.7B+2.92%
TEVA's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

TEVA revenue growth forecast

How is TEVA forecast to perform vs Drug Manufacturers - Specialty & Generic companies and vs the US market?
Company
0.83%
Industry
6.48%
Market
7.5%
TEVA's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
TEVA's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

TEVA vs Pharmaceutical Stocks

TickerPricePrice TargetUp/downsideConsensus
TEVA$9.71$13.00+33.88%Strong Buy
VTRS$9.37$10.33+10.28%Sell
NBIX$117.12$130.93+11.79%Buy
RDY$69.58N/AN/A
CTLT$40.15$50.58+25.99%Buy
View Top Pharmaceutical Stocks

Teva Pharmaceutical Industries Stock Forecast FAQ

Is Teva Pharmaceutical Industries Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NYSE: TEVA) stock is to Strong Buy TEVA stock.

Out of 2 analysts, 2 (100%) are recommending TEVA as a Strong Buy, 0 (0%) are recommending TEVA as a Buy, 0 (0%) are recommending TEVA as a Hold, 0 (0%) are recommending TEVA as a Sell, and 0 (0%) are recommending TEVA as a Strong Sell.

If you're new to stock investing, here's how to buy Teva Pharmaceutical Industries stock.

What is TEVA's revenue growth forecast for 2023-2025?

(NYSE: TEVA) Teva Pharmaceutical Industries's forecast annual revenue growth rate of 0.83% is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 6.48%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 7.5%.

Teva Pharmaceutical Industries's revenue in 2023 is $15,273,000,000.On average, 6 Wall Street analysts forecast TEVA's revenue for 2023 to be $17,208,091,696,289, with the lowest TEVA revenue forecast at $17,101,884,158,785, and the highest TEVA revenue forecast at $17,270,803,309,214. On average, 6 Wall Street analysts forecast TEVA's revenue for 2024 to be $17,199,660,871,879, with the lowest TEVA revenue forecast at $16,785,871,167,229, and the highest TEVA revenue forecast at $17,545,441,253,704.

In 2025, TEVA is forecast to generate $17,621,054,124,193 in revenue, with the lowest revenue forecast at $17,280,667,855,792 and the highest revenue forecast at $17,913,131,017,672.

What is TEVA's forecast return on assets (ROA) for 2023-2026?

(NYSE: TEVA) forecast ROA is N/A, which is lower than the forecast US Drug Manufacturers - Specialty & Generic industry average of 0.03%.

What is TEVA's Price Target?

According to 2 Wall Street analysts that have issued a 1 year TEVA price target, the average TEVA price target is $13.00, with the highest TEVA stock price forecast at $13.00 and the lowest TEVA stock price forecast at $13.00.

On average, Wall Street analysts predict that Teva Pharmaceutical Industries's share price could reach $13.00 by Nov 27, 2024. The average Teva Pharmaceutical Industries stock price prediction forecasts a potential upside of 33.88% from the current TEVA share price of $9.71.

What is TEVA's forecast return on equity (ROE) for 2023-2026?

(NYSE: TEVA) forecast ROE is N/A, which is considered weak.
©2023 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.